Save

Band 13 (2022): Ausgabe 4 (Oct 2022)

in Beneficial Microbes
eISSN:
1876-2891
Print-ISSN:
1876-2883
Verleger:
Wageningen Academic
Innovations for microbiome targeting interventions – a patent landscape analysis indicating overall patenting activity decline and promising target disease areas
Von: J.K. Timmis, D. Flaherty Roussilhon, und L.H.M. van de Burgwal
Seiten: 265–282
Publikationsdatum: 04 Oct 2022
Rotavirus immunisation status affects the efficacy of Lacticaseibacillus rhamnosus GG for the treatment of children with acute diarrhoea: a meta-analysis
Von: A. Lo Vecchio, F. Nunziata, D. Bruzzese, M.L. Conelli, und A. Guarino
Seiten: 283–294
Publikationsdatum: 04 Oct 2022
Role of gastrointestinal microbial populations, a terra incognita of the human body in the management of intestinal bowel disease and metabolic disorders
Von: J.E. Vazquez Bucheli, S.D. Todorov, und W.H. Holzapfel
Seiten: 295–318
Publikationsdatum: 04 Oct 2022
Lactation time influences the composition of Bifidobacterium and Lactobacillus at species level in human breast milk
Von: M. Ding, Y. Zheng, F. Liu, F. Tian, R.P. Ross, C. Stanton, R. Yu, J. Zhao, H. Zhang, B. Yang, und W. Chen
Seiten: 319–330
Publikationsdatum: 04 Oct 2022
Bacillus clausii UBBC-07 in the symptom management of upper respiratory tract infections in children: a double blind, placebo-controlled randomised study
Von: R.S. Madempudi, J. Neelamraju, J.J. Ahire, M. Muthukumar, S. Rudrappa, G. Gopal, und K. Nagendra
Seiten: 331–340
Publikationsdatum: 04 Oct 2022
Comparison of two probiotics in follow-on formula: Bifidobacterium animalis subsp. lactis HN019 reduced upper respiratory tract infections in Chinese infants
Von: J. Dekker, M. Quilter, und H. Qian
Seiten: 341–354
Publikationsdatum: 04 Oct 2022
Mild intermittent hypoxia exposure alters gut microbiota composition in men with overweight and obesity
Von: R.L.J. Van Meijel, K. Venema, E.E. Canfora, E.E. Blaak, und G.H. Goossens
Seiten: 355–364
Publikationsdatum: 04 Oct 2022